Authors: SARLI M FRADINGER E MORILLO S REY P ZANCHETTA J

Citation: M. Sarli et al., TREATMENT OF POST MENOPAUSAL OSTEOPOROSIS WITH INTRAVENOUS PAMIDRONATE IN PATIENTS WITH ESOPHAGOGASTRIC PATHOLOGY, Medicina, 58(5), 1998, pp. 446-452

Authors: PLOTKIN LI MATHOV I SARLI M ZANCHETTA JR PLOTKIN H LEONI J

Citation: Li. Plotkin et al., INSULIN-LIKE-GROWTH-FACTOR BINDING PROTEIN-3 LEVELS IN SERA FROM HEALTHY AND OSTEOPOROTIC WOMEN, Journal of bone and mineral research, 12, 1997, pp. 452-452

Authors: ZANCHETTA JR SPIVACOW R REY P MORILLO S INSUA A RODRIGUEZ G NEGRI A DELVALLE E MASSARI F SARLI M TALBOT JR

Citation: Jr. Zanchetta et al., INCIDENCE OF ADVERSE-EFFECTS IN OSTEOPOROTIC PATIENTS TREATED WITH ALENDRONATE, Journal of bone and mineral research, 12, 1997, pp. 465-465

Authors: MORILLO S REY P SARLI M ZANCHETTA JR

Citation: S. Morillo et al., TREATMENT OF THE REFLEX SYMPATHETIC DYSTROPHY SYNDROME WITH IV PAMIDRONATE, Journal of bone and mineral research, 12, 1997, pp. 528-528

Authors: ZANCHETTA JR SPIVACOW RF BOGADO C SARLI M PLOTKIN H ROLDAN EJA

Citation: Jr. Zanchetta et al., PROTRACTED USE, UP TO 6 YEARS, OF AN ORALAMINOBISPHOSPHONATE IN PATIENTS WITH ESTABLISHED OSTEOPOROSIS, Medicina, 57, 1997, pp. 37-44

Authors: SARLI M PLOTKIN H ZANCHETTA JR

Citation: M. Sarli et al., ALCOHOLIC OSTEOPATHY, Medicina, 54(4), 1994, pp. 363-370